Isenmann Rainer, Henne-Bruns Doris
Department of Abdominal and Transplantation Surgery, University of Ulm, Steinhoevelstrasse 9, 89075 Ulm, Germany.
Expert Rev Anti Infect Ther. 2005 Jun;3(3):393-401. doi: 10.1586/14787210.3.3.393.
Infectious complications are the leading cause of death in patients with severe acute pancreatitis. Currently, there is controversy concerning the therapeutic possibilities to reduce the incidence of bacterial infection in this disease. Numerous studies are available which apparently support the prophylactic use of antibiotics in patients with necrotizing pancreatitis. The results, however, are contradicting and interpretation is difficult as these studies have used various antibiotic drugs with different application schemes and heterogeneous study end points. This article gives a critical overview of the background of antibiotic treatment in severe acute pancreatitis, the published data on antibiotic treatment and an outlook on the topics that need to be addressed by future research.
感染性并发症是重症急性胰腺炎患者死亡的主要原因。目前,关于降低该疾病细菌感染发生率的治疗可能性存在争议。有大量研究似乎支持在坏死性胰腺炎患者中预防性使用抗生素。然而,这些研究结果相互矛盾,且由于研究使用了不同的抗生素药物、不同的应用方案以及异质性的研究终点,因此难以进行解读。本文对重症急性胰腺炎抗生素治疗的背景、已发表的抗生素治疗数据进行了批判性综述,并对未来研究需要解决的主题进行了展望。